TALLAHASSEE, Fla., Nov. 19, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Capital City Bank Group, Inc. (NASDAQ: CCBG) declared a quarterly cash dividend on its common stock of $0.28 per share. It represents a 3.7% increase over the prior quarter dividend of $0.27 per share. The dividend produces an annualized rate of $1.12 per common share and is payable on December 17, 2026, to shareowners of record as of December 3, 2026. The annualized dividend yield is 2.25% based on a closing stock price of $49.88 on November 18, 2026.
Amazon is showing pop-up notices to some users of its app and website warning against a New York City bill that aims to disrupt its contracted delivery model. A banner on its homepage states the bill, dubbed the Delivery Protection Act, "could add up to $5 per order.
Speed safety technology is being deployed at 33 high-risk locations across the city, with phased implementation beginning with an initial six sites MESA, Ariz., Nov. 19, 2026 /PRNewswire/ -- Verra Mobility Corporation (NASDAQ: VRRM), a leading provider of smart mobility technology solutions, announced today that the City of San Jose has approved a contract with the company to design, build, operate, and maintain a speed safety program across the city.
LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave, a leading AI-powered patient engagement and payments platform built for healthcare practices, today announced a $5,000 Healthcare Heroes grant to the People's Health Clinic in Park City, Utah, along with promotional content to support its outreach and fundraising efforts. The nonprofit clinic provides free, high-quality healthcare to uninsured individuals and families in Summit and Wasatch counties. The nonprofit clinic provides free, high-quality healthcare.
BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop arranged a $270,000,000 refinancing for The Greyson, a 28-story, 622-unit, Class A mixed-use residential tower in Jersey City.
DES MOINES, Iowa--(BUSINESS WIRE)--Hy-Vee, Inc. ("Hy-Vee"), a leading grocery store in the Midwest, and Oscar, one of the fastest-growing insurers in the individual market and part of Oscar Health (NYSE: OSCR), today announced that Hy-Vee Health with Oscar is expanding statewide across Iowa and launching in Kansas City and Omaha for 2027 Open Enrollment.1 Beginning Nov. 1, 2026, individuals and families can enroll in Hy-Vee Health with Oscar directly through HealthCare.gov for 2027 coverage. Em.
Los Angeles, California, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (the “Company” or “Portsmouth”) announced financial results for the three months ended September 30, 2026, the first quarter of fiscal 2027. Portsmouth operates in two reportable segments: Hotel Operations and Investment Transactions. The quarter was affected by a ten-day City-mandated shutdown of its Hilton San Francisco Financial District hotel (the “Hotel”) for removal of the pedestrian bridge connecting the Hotel to Portsmouth Square park. The Hotel reopened on August 10, 2026.
Corporate networking hours can be painfully awkward. Picture it: dozens of professionals clutching lukewarm drinks, trading similar elevator pitches, and desperately scanning badges to find someone worth talking to.
INDIANA COUNTY, Pa.--(BUSINESS WIRE)--Homer City Generation, L.P., today announced that the delivery and setting of the first two of seven total GE Vernova 7HA.02 natural gas turbines to the Homer City Energy Campus were completed in late September 2026. The turbines are the first two of seven high-efficiency 7HA.02 natural gas turbines that GE Vernova is supplying to the campus, which will generate up to 4.4 gigawatts (GW) of power once complete. Deliveries of the remaining turbines will contin.
LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling metastatic colorectal cancer, part.